Grants for Special district governments - Health

This funding opportunity provides financial support for research sites to study Type 1 diabetic nephropathy by recruiting patients, conducting kidney biopsies, and collecting data to identify new treatment targets and improve precision medicine approaches.

Substance use needs to be better incorporated into interventions for the engagement and retention of sexual minority persons in prevention and care with attention to emergent interventions such as long-acting PrEP. Social determinants of health associated with HIV and problematic substance use such as homelessness and criminal justice involvement also demonstrate disproportionate impact among sexual and gender minorities and need attention. Changing self-definition of sexual minority status has implications for outreach and provider stigma and needs to be better integrated into interventions. This initiative will address these gap areas and support epidemiologic, intervention, and implementation research that incorporates attention to HIV as a syndemic including comorbidities such as STIs, HCV, and psychiatric disorder.

This grant provides funding to U.S. institutions to foster collaboration and support early-career researchers in benign urology through training, resource sharing, and professional development opportunities.

This funding opportunity supports a central coordinating center that will enhance collaboration and provide resources for research in nonmalignant hematology, particularly aimed at fostering the development of junior investigators and innovative projects across multiple institutions.

This funding opportunity supports innovative research projects that aim to improve the use of genomic information in clinical care, particularly for diverse and underrepresented populations, while addressing health disparities and enhancing the integration of genomic medicine into healthcare practices.

The United Airlines Trust Fund was established in recognition of Siouxland's response to the United Flight 232 incident in 1989. This grant supports organizations and government units within a 50-mile radius of Sioux City, Iowa. Eligible entities include 501(c)(3) organizations and qualified government units. The fund allocates two-thirds of its annual net income to scholarships and one-third to community grants. These grants support projects promoting public safety, health care, crisis management, and community preparedness, with a focus on social services, education, and training of public personnel. Grants typically do not exceed $2,500, and the selection is based on proposal merit, relative need, and potential community impact. Grant renewed every year. Grant Annual opening/closing deadline: February 15th to May 15th

This funding opportunity provides financial support for research on the role of inflammasomes in the brain related to HIV and substance use disorders, targeting innovative studies that explore their impact on inflammation and neurocognitive health.

This grant provides funding for interdisciplinary research teams to explore the ethical implications of new neurotechnologies and brain science advancements, focusing on issues like data privacy, informed consent, and public attitudes toward brain research.

This funding opportunity supports the development of innovative medical devices aimed at diagnosing and treating pain or opioid use disorder, targeting researchers and organizations focused on non-addictive solutions in healthcare.

With this solicitation, OJJDP seeks applications for funding to support cross-system collaboration to improve responses and outcomes for youth under the age of 18 or youth under the jurisdiction of the juvenile justice system with mental health disorders (MHD) or co-occurring mental health and substance use disorders (MHSUDs) who come in contact with the juvenile justice system. This program supports public safety efforts through partnerships with youth justice, mental health, and substance use agencies to enhance responses to justice-involved youth with MHD and MHSUDs.

This funding opportunity supports organizations conducting large-scale clinical trials focused on innovative treatments for vision disorders, ensuring effective management and oversight of the research process.

This grant provides funding to organizations that will coordinate statewide meetings to develop strategies for engaging and connecting individuals with HIV to essential healthcare services.

This funding opportunity supports innovative researchers and teams in the U.S. who propose groundbreaking projects that could significantly advance biomedical and social sciences, without the need for preliminary data.

The "Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation" grant aims to provide early-stage funding for the development and testing of prototypes, diagnostic disease target assays, and research tools to improve the treatment of HLBS diseases and disorders, with the goal of advancing these projects to a stage where they can attract further development support.

This Notice of Funding Opportunity Announcement (NOFO) intends to supports studies that are both necessary and sufficient to inform the planning of a Phase II-IV clinical trial within NHLBI's mission. The NHLBI expects that applications to this NOFO will describe the planned clinical trial and in so doing demonstrate that the proposed (R34) research is scientifically necessary to design or plan the subsequent trial. Furthermore, this NOFO will support research projects that are designed to provide results that will be sufficient to inform the future trial without further studies. The planned Phase II, III, or IV trial must be primarily intended to test the efficacy, safety, clinical management, or implementation of intervention(s) in the prevention and/or treatment of heart, lung, blood, and sleep disorders. In contrast to the study start up or preparation phase of NHLBI funding opportunities for clinical trials (as described at https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/clinical-trials-optimization), the R34 mechanism is intended to provide new information that answers a scientific or operational question(s) which may be pragmatic in nature and, therefore, informs the final development of a Phase II-IV clinical trial. Regardless of the results of the R34, support of the proposed future clinical trial will require a new application.

The "Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression" grant aims to fund the development and early testing of predictive tools or biomarkers that can help determine the most effective treatment for individual patients suffering from depression.

This funding opportunity provides financial support for researchers and innovators to develop advanced technologies and platforms that improve the detection, diagnosis, and treatment of heart, lung, blood, and sleep-related health issues.

AmeriCorps improves lives, strengthens communities, and fosters civic engagement through service and volunteering. AmeriCorps brings people together to tackle some of the countrys most pressing challenges through national service and volunteerism. AmeriCorps members and AmeriCorps Seniors volunteers serve with organizations dedicated to the improvement of communities and those serving. AmeriCorps helps make service a cornerstone of our national culture. This funding announcement is an opportunity for communities to apply for funding to engage adults ages 55 and older in tackling the communitys most pressing needs through the AmeriCorps Seniors RSVP program. This is an open competition across all states and territories.

This funding opportunity supports the development of essential research resources for organizations working on allergy, immunology, and infectious diseases, benefiting the broader scientific community.

This funding opportunity supports researchers exploring urgent issues in substance use, such as sudden spikes in drug overdoses or emerging trends in marijuana policy, requiring quick responses to inform public health and policy decisions.